Discovery and structure-based design of 4,6-diaminonicotinamides as potent and selective IRAK4 inhibitors

被引：16

作者：

Bhide, Rajeev S. ^{[1
]}

Keon, Alec ^{[1
]}

Weigelt, Carolyn ^{[2
]}

Sack, John S. ^{[2
]}

Schmidt, Robert J. ^{[1
]}

Lin, Shuqun ^{[1
]}

Xiao, Hai-Yun ^{[1
]}

Spergel, Steven H. ^{[1
]}

Kempson, James ^{[1
]}

Pitts, William J. ^{[1
]}

Carman, Julie ^{[3
]}

Poss, Michael A. ^{[1
]}

机构：

[1] Bristol Myers Squibb Co, Discovery Chem, Res & Dev, Route 206 & Prov Line Rd, Princeton, NJ 08543 USA

[2] Bristol Myers Squibb Co, Mol Struct & Design, Res & Dev, Route 206 & Prov Line Rd, Princeton, NJ 08543 USA

[3] Bristol Myers Squibb Co, Immunosci Biol, Res & Dev, Route 206 & Prov Line Rd, Princeton, NJ 08543 USA

来源：

BIOORGANIC & MEDICINAL CHEMISTRY LETTERS | 2017年 / 27卷 / 21期

关键词：

IRAK4; 4,6-Diaminonicotinamide; Rheumatoid arthritis; Autoimmune disease; KINASE; 4; IRAK4; IMMUNITY; DISEASES; INNATE;

D O I：

10.1016/j.bmcl.2017.09.029

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

The identification of small molecule inhibitors of IRAK4 for the treatment of autoimmune diseases has been an area of intense research. We discovered novel 4,6-diaminonicotinamides which potently inhibit IRAK4. Optimization efforts were aided by X-ray crystal structures of inhibitors bound to IRAK4. Structure activity relationship (SAR) studies led to the identification of compound 29 which exhibited sub-micromolar potency in a LTA stimulated cellular assay. (C) 2017 Elsevier Ltd. All rights reserved.

引用

页码：4908 / 4913

页数：6

共 50 条

[1] Discovery and optimization of a potent and selective indazolamine series of IRAK4 inhibitors
Zhai, Wenqiang
Lu, Yongping
Zhu, Yabo
Zhou, Mengguang
Ye, Cheng
Shi, Zheng-Zheng
Qian, Wenjian
Hu, Taishan
Chen, Lei
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2021, 31
[2] Development of Potent and Selective Pyrazolopyrimidine IRAK4 Inhibitors
Bryan, Marian C.
Drobnick, Joy
Gobbi, Alberto
Kolesnikov, Aleksandr
Chen, Yongsheng
Rajapaksa, Naomi
Ndubaku, Chudi
Feng, Jianwen
Chang, Willy
Francis, Ross
Yu, Christine
Choo, Edna F.
DeMent, Kevin
Ran, Yingqing
An, Le
Emson, Claire
Huang, Zhiyu
Sujatha-Bhaskar, Swathi
Brightbill, Hans
DiPasquale, Antonio
Maher, Jonathan
Wai, John
McKenzie, Brent S.
Lupardus, Patrick J.
Zarrin, Ali A.
Kiefer, James R.
JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (13) : 6223 - 6240
[3] Discovery of Potent Benzolactam IRAK4 Inhibitors with Robust in Vivo Activity
Rajapaksa, Naomi S.
Gobbi, Alberto
Drobnick, Joy
Do, Steven
Kolesnikov, Aleksandr
Liang, Jun
Chen, Yongsheng
Sujatha-Bhaskar, Swathi
Huang, Zhiyu
Brightbill, Hans
Francis, Ross
Yu, Christine
Choo, Edna F.
DeMent, Kevin
Ran, Yingqing
An, Le
Emson, Claire
Maher, Jonathan
Wai, John
McKenzie, Brent S.
Lupardus, Patrick J.
Zarrin, Ali A.
Kiefer, James R.
Bryan, Marian C.
ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (03): : 327 - 333
[4] Discovery of 5-Aryl-2,4-diaminopyrimidine Compounds as Potent and Selective IRAK4 Inhibitors
Chen, Yan
Singh, Rajinder
Lin, Nan
Taylor, Vanessa
Masuda, Esteban S.
Payan, Donald G.
ACS MEDICINAL CHEMISTRY LETTERS, 2022, 13 (04): : 714 - 719
[5] Potent and Selective Amidopyrazole Inhibitors of IRAK4 That Are Efficacious in a Rodent Model of Inflammation
McElroy, William T.
Tan, Zheng
Ho, Ginny
Paliwal, Sunil
Li, Guoqing
Seganish, W. Michael
Tulshian, Deen
Tata, James
Fischmann, Thierry O.
Sondey, Christopher
Bian, Hong
Bober, Loretta
Jackson, James
Garlisi, Charles G.
Devito, Kristine
Fossetta, James
Lundell, Daniel
Niu, Xiaoda
ACS MEDICINAL CHEMISTRY LETTERS, 2015, 6 (06): : 677 - 682
[6] Bicyclic pyrimidine compounds as potent IRAK4 inhibitors
Chen, Yan
Tso, Kin
Heckrodt, Thilo J.
Li, Hui
Yen, Rose
Lin, Nan
Singh, Rajinder
Taylor, Vanessa
Masuda, Esteban S.
Park, Gary
Payan, Donald G.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2022, 73
[7] Optimization of Nicotinamides as Potent and Selective IRAK4 Inhibitors with Efficacy in a Murine Model of Psoriasis
Nair, Satheesh
Kumar, Sreekantha Ratna
Paidi, Venkatram Reddy
Sistla, Ramesh
Kantheti, Durgarao
Polimera, Subba Rao
Thangavel, Soodamani
Mukherjee, Amrita Jha
Das, Mitalee
Bhide, Rajeev S.
Pitts, William J.
Murugesan, Natesan
Dudhgoankar, Shailesh
Nagar, Jignesh
Subramani, Siva
Mazumder, Debarati
Carman, Julie A.
Holloway, Deborah A.
Li, Xin
Fereshteh, Mark P.
Ruepp, Stefan
Palanisamy, Kamalavenkatesh
Mariappan, T. Thanga
Maddi, Srinivas
Saxena, Ajay
Elzinga, Paul
Chimalakonda, Anjaneya
Ruan, Qian
Ghosh, Kaushik
Bose, Sucharita
Sack, John
Yan, Chunhong
Kiefer, Susan E.
Xie, Dianlin
Newitt, John A.
Saravanakumar, S. Pon
Rampulla, Richard A.
Barrish, Joel C.
Carter, Percy H.
Hynes, John, Jr.
ACS MEDICINAL CHEMISTRY LETTERS, 2020, 11 (07): : 1402 - 1409
[8] Structure-based design and discovery of potent and selective KDM5 inhibitors
Nie, Zhe
Shi, Lihong
Lai, Chon
O'Connell, Shawn M.
Xu, Jiangchun
Stansfield, Ryan K.
Hosfield, David J.
Veal, James M.
Stafford, Jeffrey A.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2018, 28 (09) : 1490 - 1494
[9] Structure-based design of highly potent and selective Cdk4 inhibitors.
Honma, T
Hayashi, K
Yoshizumi, T
Ikeura, C
Ikuta, M
Suzuki-Takahashi, I
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2003, 226 : U437 - U438
[10] Advances in the Discovery of Small-Molecule IRAK4 Inhibitors
Hynes, John, Jr.
Nair, Satheesh K.
ANNUAL REPORTS IN MEDICINAL CHEMISTRY, VOL 49, 2014, 49 : 117 - 133

← 1 2 3 4 5 →